{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:50:28Z","timestamp":1776487828700,"version":"3.51.2"},"reference-count":17,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018918","name":"Microport\u00ae","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018918","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Pacemakers enable continuous long-term surveillance of atrial fibrillation detected by implanted devices. Circulating biomarkers reflecting endothelial dysfunction, inflammation, and myocardial stress may help identify patients at risk for atrial fibrillation (AF) progression and higher arrhythmic burden. Methods: This analysis included patients from the prospective ACaSA study (NCT05127720) with a dual chamber pacemaker (Microport\u00ae BOREA DR or TEO DR) and monitored weekly via remote monitoring technology (SMARTVIEW\u00ae). Individuals with permanent AF or single-chamber systems were excluded. Baseline plasma concentrations of angiopoietin-2 (ANGPT2), growth differentiation factor-15 (GDF-15), fibroblast growth factor-23 (FGF-23), bone morphogenetic protein-10 (BMP10), and tumor necrosis factor\u2013related apoptosis-inducing ligand receptor-2 (TRAIL-R2) were quantified using enzyme-linked immunosorbent assays. N-terminal pro-B-type natriuretic peptide (NT-proBNP) was measured using electrochemiluminescence immunoassay. Biomarkers were log2-transformed, with values below assay detection limits imputed at half the lower limit of detection. Two endpoints were assessed following a 30-day blanking period: (1) progression to persistent AF, defined as \u22657 consecutive days with &gt;99% daily AF burden, analyzed using Cox regression; and (2) AF burden, calculated as total AF time normalized to monitored days and categorized as &lt;25%, 25\u201375%, or &gt;75%, analyzed using multinomial logistic regression. Multivariable models were adjusted for age, sex, heart failure, diabetes, and prior myocardial infarction; Cox models were limited to age, sex, and heart failure due to fewer events. Results: A total of 223 patients were included (median age 75 years; 37.2% women). During follow-up, 28 patients (13.3%) progressed to persistent AF. Higher baseline ANGPT2 was the strongest predictor of progression (HR per doubling 1.83, 95% CI 1.27\u20132.66, p = 0.001), followed by GDF-15 (HR 1.52, 95% CI 1.03\u20132.24, p = 0.036). In the burden analysis, ANGPT2 demonstrated a pronounced graded relationship with arrhythmic load, with markedly increased odds of high (&gt;75%) AF burden (OR 8.31, 95% CI 2.63\u201326.26, p &lt; 0.001). GDF-15 independently predicted both medium (OR 2.05, p = 0.025) and high burden (OR 2.32, p = 0.037). NT-proBNP displayed a borderline association with high burden (OR 2.02, p = 0.061). No significant associations were observed for FGF-23, BMP10, or TRAIL-R2. Conclusions: In continuously monitored pacemaker patients, ANGPT2 and GDF-15 emerged as key biomarkers associated with AF disease severity. ANGPT2 was strongly linked to both progression to persistent AF and high AF burden, whereas GDF-15 consistently predicted higher AF burden and also contributed to risk of progression. These findings highlight endothelial and inflammatory pathways as potential markers of atrial disease progression.<\/jats:p>","DOI":"10.3390\/biomedicines14040902","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:37:19Z","timestamp":1776325039000},"page":"902","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiopoietin-2 and Growth Differentiation Factor-15 as Predictors of Device-Detected Atrial Fibrillation Burden"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4889-2177","authenticated-orcid":false,"given":"Valentin","family":"Bilgeri","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5908-2923","authenticated-orcid":false,"given":"Philipp","family":"Spitaler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Gavranovic-Novakovic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Dolejsi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Rockenschaub","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Messner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc Michael","family":"Zaruba","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-1822","authenticated-orcid":false,"given":"Fabian","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Hindenburgdamm 30, 12203 Berlin, Germany"},{"name":"Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit\u00e9, Hindenburgdamm 30, 12203 Berlin, Germany"},{"name":"Institute of Active Polymers and Berlin-Brandenburg Center for Regenerative Therapies, Helmholtz-Zentrum Hereon, 14513 Teltow, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agne","family":"Adukauskaite","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1324-0815","authenticated-orcid":false,"given":"Markus","family":"St\u00fchlinger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard Erich","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Landesinstitut f\u00fcr Integrierte Versorgung Tirol, Tirol Kliniken, 6020 Innsbruck, Austria"},{"name":"Division for Digital Medicine and Telehealth, University for Health Sciences, Medical Informatics and Technology (UMIT-Tirol), 6060 Hall in Tirol, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4049-4494","authenticated-orcid":false,"given":"Pietro","family":"Lacaita","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6755-4399","authenticated-orcid":false,"given":"Gudrun","family":"Feuchtner","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1866-7159","authenticated-orcid":false,"given":"Peter","family":"Willeit","sequence":"additional","affiliation":[{"name":"Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck, 6020 Innsbruck, Austria"},{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK"},{"name":"Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, 1090 Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0421-2110","authenticated-orcid":false,"given":"Wolfgang","family":"Dichtl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e010304","DOI":"10.1161\/CIRCEP.121.010304","article-title":"Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients with Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices","volume":"15","author":"Chew","year":"2022","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/eurheartj\/ehae373","article-title":"Atrial fibrillation burden: A new outcome predictor and therapeutic target","volume":"45","author":"Becher","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"euaf019","DOI":"10.1093\/europace\/euaf019","article-title":"Atrial fibrillation burden in clinical practice, research, and technology development: A clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association","volume":"27","author":"Doehner","year":"2025","journal-title":"Europace"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e007607","DOI":"10.1161\/CIRCEP.119.007607","article-title":"Protein Biomarkers and Risk of Atrial Fibrillation: The FHS","volume":"13","author":"Staerk","year":"2020","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","article-title":"Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community","volume":"121","author":"Schnabel","year":"2010","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/europace\/euu175","article-title":"B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: The CHARGE-AF Consortium of community-based cohort studies","volume":"16","author":"Sinner","year":"2014","journal-title":"Europace"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","article-title":"Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure","volume":"43","author":"Chong","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","article-title":"Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial","volume":"130","author":"Wallentin","year":"2014","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/CIRCULATIONAHA.118.034125","article-title":"Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation","volume":"138","author":"Sharma","year":"2018","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/clc.22844","article-title":"Growth differentiation factor 15 is associated with left atrial\/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation","volume":"41","author":"Hu","year":"2018","journal-title":"Clin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehw054","article-title":"The ABC (age, biomarkers, clinical history) stroke risk score: A biomarker-based risk score for predicting stroke in atrial fibrillation","volume":"37","author":"Hijazi","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"euae028","DOI":"10.1093\/europace\/euae028","article-title":"Disturbed atrial metabolism, shear stress, and cardiac load contribute to atrial fibrillation after ablation: AXAFA biomolecule study","volume":"26","author":"Chua","year":"2024","journal-title":"Europace"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1093\/eurheartj\/ehae611","article-title":"Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: The EAST-AFNET 4 biomolecule study","volume":"45","author":"Fabritz","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nm1351","article-title":"Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation","volume":"12","author":"Fiedler","year":"2006","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.124.072009","article-title":"Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention","volume":"151","author":"Gragnano","year":"2025","journal-title":"Circulation"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/902\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:14:12Z","timestamp":1776485652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biomedicines14040902"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14040902","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}